REG - Pulsar Helium Inc. - Oscillate Update, Warrant Exercise & TVR

Pulsar HeliumAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260309:nRSI7545Va&default-theme=true

RNS Number : 7545V  Pulsar Helium Inc.  09 March 2026

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA
OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR
CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE,
PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR
REGULATIONS.

NEWS RELEASE | MARCH 9, 2026 | CASCAIS, PORTUGAL

PULSAR HELIUM PROVIDES UPDATE ON TRANSACTION WITH OSCILLATE PLC, WARRANT
EXERCISE AND TVR

Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) ("Pulsar" or the
"Company"), a primary helium company, provides an update following its
announcements on November 4, 2025, December 19, 2025, January 21, 2026, and
February 10, 2026, regarding its option to acquire up to 100% of the shares of
Quantum Hydrogen Inc. ("Quantum"), a 100% owned subsidiary of Oscillate PLC
("Oscillate"), in an all-share transaction (the "Transaction").

On December 18, 2025, the Company issued a total of 292,560 common shares (the
"Consideration Shares") to Oscillate, satisfying the first and second monthly
share option tranches valued at US$80,000 each, at a VWAP of C$0.7797 for
tranche one and C$0.7543 for tranche two.

On January 20, 2026, the Company issued an additional 145,434 Consideration
Shares to Oscillate, satisfying the third monthly share option tranche of
US$80,000 at a VWAP of C$0.7556.

On February 9, 2026, the Company issued an additional 80,947 Consideration
Shares to Oscillate, satisfying the fourth monthly share option tranche of
US$80,000 at a VWAP of C$1.3508.

On March 6, 2026, the Company issued an additional 66,022 Consideration Shares
to Oscillate, satisfying the fifth and final monthly share option tranche of
US$80,000 at a VWAP of C$1.6581.

Under the terms of the agreement with Oscillate, the Company has now acquired
80% of the shares of Quantum upon having issued to Oscillate all of the
required monthly tranches of Consideration Shares. The Company also has the
option until May 3, 2027, to acquire the remaining 20% of the shares of
Quantum from Oscillate in exchange for US$400,000 of Consideration Shares to
be issued in 5 instalments of US$80,000 of Consideration Shares each after the
Company has provided notice to Oscillate that it wishes to exercise such
option. The Company will evaluate this option in coming months, and prior to
the May 3, 2027, deadline date.

The Consideration Shares issued in connection with the Transaction are subject
to a four-month-and-one-day hold period from the date of issuance.

Warrant Exercise

In addition, the Company notes that on March 6, 2026, 500,000 share purchase
warrants ("Warrant Exercise Shares") - issued as part of its offering that
closed on October 14, 2024 - were exercised at a price of £0.25 per share,
generating cash proceeds for the Company of £125,000.

Admission to AIM and Total Voting Rights

Application is being made to the London Stock Exchange plc for the admission
of the 500,000 Warrant Exercise Shares to be admitted to trading on AIM, which
is expected to occur and dealings commence at 8:00 a.m. on or around March 10,
2026 ("First Admission"). Application is also being made to the London Stock
Exchange plc for the admission of the 66,022 Consideration Shares to be
admitted to trading on AIM, which is expected to occur, and dealings commence
at 8:00 a.m. on or around March 12, 2026 ("Second Admission").

The new common shares will rank pari passu with the Company's existing common
shares.

On First Admission, the total number of common shares in issue will be
180,642,697 with voting rights. On Second Admission, the total number of
common shares in issue will be 180,708,719 with voting rights. These figures
may be used by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in, the Company's issued share capital pursuant to
the Company's Articles.

On behalf of Pulsar Helium Inc.

"Thomas Abraham-James"

President, CEO and Director

Further Information:

Pulsar Helium Inc.

connect@pulsarhelium.com

+ 1 (218) 203-5301 (USA/Canada)

+44 (0) 2033 55 9889 (United Kingdom)

https://pulsarhelium.com (https://pulsarhelium.com)

https://ca.linkedin.com/company/pulsar-helium-inc
(https://ca.linkedin.com/company/pulsar-helium-inc) .

Strand Hanson Limited

(Nominated & Financial Adviser, and Broker)

Ritchie Balmer / Rob Patrick / Richard Johnson

+44 (0) 207 409 3494

Yellow Jersey PR Limited

(Financial PR)

Charles Goodwin / Annabelle Wills

+44 777 5194 357

pulsarhelium@yellowjerseypr.com (mailto:pulsarhelium@yellowjerseypr.com)

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of
the London Stock Exchange and listed on the TSX Venture Exchange with the
ticker PLSR, as well as on the OTCQB with the ticker PSRHF. Pulsar's portfolio
consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu
helium project in Greenland. Pulsar is the first mover in both locations with
primary helium occurrences not associated with the production of hydrocarbons
identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUPUGUWUPQGRQ



            Copyright 2019 Regulatory News Service, all rights reserved